首页> 外文OA文献 >Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
【2h】

Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.

机译:在急性感染患者中,抗逆转录病毒治疗8-18个月后,血液和次级淋巴器官之间的功能性HIV特异性CD8 T淋巴细胞分布。

摘要

OBJECTIVES: To assess whether drug-induced suppression of the plasma viral load is associated with selective differential distribution of virus-specific CD8 T cells between the blood and secondary lymphoid organs. METHODS: HIV-specific CD8 T lymphocyte responses were quantified in matched peripheral blood and lymph node samples from seven patients starting treatment shortly after infection, who received antiretroviral therapy (ART) for a median of 14 months. Cells recovered from samples were subjected to IFN-gamma ELISPOT analysis. A series of synthetic peptides corresponding to previously characterized cytotoxic T lymphocyte epitopes restricted by HLA I molecules present in each patient were used as antigens, together with appropriate positive and negative controls. RESULTS: HIV-specific CD8 T lymphocyte responses were found in six of the seven patients. The observed frequencies of HIV-specific CD8 T lymphocytes and the pattern of epitope recognition was identical within the two compartments. These results also confirm the observation that functional HIV-specific CD8 T cells are preserved on ART in most patients initiating treatment at the time of primary HIV-1 infection. CONCLUSION: This investigation demonstrated that patterns of antigenic immunodominance as well as frequencies of HIV-specific CD8 T lymphocytes are similar in blood and lymphoid tissue compartments in HIV-infected individuals. These findings support current approaches to the identification of HIV-specific CD8 T lymphocyte reactivity based on leukocytes isolated from blood even in patients with ART-induced suppression of viral load.
机译:目的:评估药物诱导的血浆病毒载量抑制是否与病毒特异性CD8 T细胞在血液和次级淋巴器官之间的选择性差异分布有关。方法:从7名感染后不久开始治疗的患者的匹配的外周血和淋巴结样本中,对HIV特异的CD8 T淋巴细胞反应进行定量,他们接受了抗逆转录病毒疗法(ART),中位时间为14个月。从样品中回收的细胞进行IFN-γELISPOT分析。将与每个患者中存在的HLA I分子限制的先前表征的细胞毒性T淋巴细胞表位相对应的一系列合成肽与适当的阳性和阴性对照一起用作抗原。结果:7名患者中有6名发现了HIV特异性CD8 T淋巴细胞反应。在两个区室中观察到的HIV特异性CD8 T淋巴细胞的频率和表位识别的模式相同。这些结果也证实了这样的观察,即在最初感染HIV-1时开始治疗的大多数患者中,功能性HIV特异性CD8 T细胞保留在ART上。结论:这项研究表明,在HIV感染者的血液和淋巴组织区室中,抗原免疫优势的模式以及HIV特异性CD8 T淋巴细胞的频率相似。这些发现支持当前基于从血液中分离的白细胞来鉴定HIV特异性CD8 T淋巴细胞反应性的方法,即使是在ART诱导的病毒载量抑制患者中也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号